ERBB2 and breast neoplasm: This GEMM recapitulates the stages of human breast tumor progression, including distant metastases, and expresses biomarkers that define human breast tumor subtypes, such as loss of estrogen and progesterone receptors and expression of ErbB2/HER2.44